Six  ||| S:0 E:4 ||| CD
Cases  ||| S:4 E:10 ||| NNS
of  ||| S:10 E:13 ||| IN
Myofibroma  ||| S:13 E:24 ||| NNP
-  ||| S:24 E:26 ||| :
The  ||| S:26 E:30 ||| DT
Adult  ||| S:30 E:36 ||| NNP
Counterpart of  ||| S:36 E:51 ||| NNP
Infantile  ||| S:51 E:61 ||| NNP
Myofibromatosis ||| S:61 E:76 ||| NNP
:  ||| S:76 E:78 ||| :
Case Report  ||| S:78 E:90 ||| CD
The  ||| S:90 E:94 ||| DT
adult  ||| S:94 E:100 ||| NN
counterpart  ||| S:100 E:112 ||| NN
of  ||| S:112 E:115 ||| IN
infantile  ||| S:115 E:125 ||| JJ
myofibromatosis  ||| S:125 E:141 ||| NN
is  ||| S:141 E:144 ||| VBZ
rare  ||| S:144 E:149 ||| JJ
and  ||| S:149 E:153 ||| CC
is  ||| S:153 E:156 ||| VBZ
known  ||| S:156 E:162 ||| VBN
as  ||| S:162 E:165 ||| IN
myofibroma ||| S:165 E:175 ||| NN
.  ||| S:175 E:177 ||| .
Cases  ||| S:177 E:183 ||| NNS
are  ||| S:183 E:187 ||| VBP
rare ||| S:187 E:191 ||| JJ
,  ||| S:191 E:193 ||| ,
and  ||| S:193 E:197 ||| CC
previous  ||| S:197 E:206 ||| JJ
ones  ||| S:206 E:211 ||| NNS
have  ||| S:211 E:216 ||| VBP
been  ||| S:216 E:221 ||| VBN
reported  ||| S:221 E:230 ||| VBN
as  ||| S:230 E:233 ||| IN
isolated  ||| S:233 E:242 ||| JJ
case  ||| S:242 E:247 ||| NN
reports ||| S:247 E:254 ||| NNS
;  ||| S:254 E:256 ||| :
hence ||| S:256 E:261 ||| RB
,  ||| S:261 E:263 ||| ,
there  ||| S:263 E:269 ||| EX
has  ||| S:269 E:273 ||| VBZ
been  ||| S:273 E:278 ||| VBN
no  ||| S:278 E:281 ||| DT
consensus  ||| S:281 E:291 ||| NN
regarding  ||| S:291 E:301 ||| VBG
the  ||| S:301 E:305 ||| DT
clinical  ||| S:305 E:314 ||| JJ
presentation ||| S:314 E:326 ||| NN
,  ||| S:326 E:328 ||| ,
surgical  ||| S:328 E:337 ||| JJ
reconstruction ||| S:337 E:351 ||| NN
,  ||| S:351 E:353 ||| ,
histological  ||| S:353 E:366 ||| JJ
features ||| S:366 E:374 ||| NNS
,  ||| S:374 E:376 ||| ,
and  ||| S:376 E:380 ||| CC
recurrence  ||| S:380 E:391 ||| NN
of  ||| S:391 E:394 ||| IN
hand  ||| S:394 E:399 ||| NN
myofibromas ||| S:399 E:410 ||| NN
.  ||| S:410 E:412 ||| .
Over  ||| S:412 E:417 ||| IN
a  ||| S:417 E:419 ||| DT
10-year  ||| S:419 E:427 ||| JJ
period ||| S:427 E:433 ||| NN
,  ||| S:433 E:435 ||| ,
the  ||| S:435 E:439 ||| DT
senior  ||| S:439 E:446 ||| JJ
author  ||| S:446 E:453 ||| NN
treated  ||| S:453 E:461 ||| VBD
6 patients ||| S:461 E:471 ||| CD
.  ||| S:471 E:473 ||| .
We  ||| S:473 E:476 ||| PRP
review  ||| S:476 E:483 ||| VB
our  ||| S:483 E:487 ||| PRP$
cases  ||| S:487 E:493 ||| NNS
as  ||| S:493 E:496 ||| IN
well  ||| S:496 E:501 ||| RB
as  ||| S:501 E:504 ||| IN
6  ||| S:504 E:506 ||| CD
previously  ||| S:506 E:517 ||| RB
reported  ||| S:517 E:526 ||| VBN
cases ||| S:526 E:531 ||| NNS
.  ||| S:531 E:533 ||| .
The  ||| S:533 E:537 ||| DT
presentation  ||| S:537 E:550 ||| NN
is  ||| S:550 E:553 ||| VBZ
usually  ||| S:553 E:561 ||| RB
a  ||| S:561 E:563 ||| DT
single  ||| S:563 E:570 ||| JJ
hand  ||| S:570 E:575 ||| NN
mass  ||| S:575 E:580 ||| NN
in  ||| S:580 E:583 ||| IN
a  ||| S:583 E:585 ||| DT
young  ||| S:585 E:591 ||| JJ
adult ||| S:591 E:596 ||| NN
.  ||| S:596 E:598 ||| .
The  ||| S:598 E:602 ||| DT
tumor  ||| S:602 E:608 ||| NN
may  ||| S:608 E:612 ||| MD
arise  ||| S:612 E:618 ||| VB
from  ||| S:618 E:623 ||| IN
the  ||| S:623 E:627 ||| DT
lower  ||| S:627 E:633 ||| JJR
dermis  ||| S:633 E:640 ||| NNS
or  ||| S:640 E:643 ||| CC
from  ||| S:643 E:648 ||| IN
deeper  ||| S:648 E:655 ||| JJR
fibrous  ||| S:655 E:663 ||| JJ
structures  ||| S:663 E:674 ||| NNS
of  ||| S:674 E:677 ||| IN
the  ||| S:677 E:681 ||| DT
hand  ||| S:681 E:686 ||| NN
including  ||| S:686 E:696 ||| VBG
the  ||| S:696 E:700 ||| DT
palmar  ||| S:700 E:707 ||| JJ
fascia ||| S:707 E:713 ||| NN
.  ||| S:713 E:715 ||| .
Tumors  ||| S:715 E:722 ||| NNS
that  ||| S:722 E:727 ||| WDT
arise  ||| S:727 E:733 ||| VBP
from  ||| S:733 E:738 ||| IN
the  ||| S:738 E:742 ||| DT
dermis  ||| S:742 E:749 ||| NNS
are  ||| S:749 E:753 ||| VBP
best  ||| S:753 E:758 ||| RB
treated  ||| S:758 E:766 ||| VBN
by  ||| S:766 E:769 ||| IN
skin  ||| S:769 E:774 ||| NN
excision  ||| S:774 E:783 ||| NN
to  ||| S:783 E:786 ||| TO
ensure  ||| S:786 E:793 ||| VB
complete  ||| S:793 E:802 ||| JJ
excision ||| S:802 E:810 ||| NN
.  ||| S:810 E:812 ||| .
Histologically ||| S:812 E:826 ||| NNP
,  ||| S:826 E:828 ||| ,
the  ||| S:828 E:832 ||| DT
tumor  ||| S:832 E:838 ||| NN
is  ||| S:838 E:841 ||| VBZ
composed  ||| S:841 E:850 ||| VBN
of  ||| S:850 E:853 ||| IN
highly  ||| S:853 E:860 ||| RB
cellular  ||| S:860 E:869 ||| JJ
myofibroblast  ||| S:869 E:883 ||| JJ
proliferation  ||| S:883 E:897 ||| NN
and  ||| S:897 E:901 ||| CC
is  ||| S:901 E:904 ||| VBZ
strongly  ||| S:904 E:913 ||| RB
positive  ||| S:913 E:922 ||| JJ
to  ||| S:922 E:925 ||| TO
smooth  ||| S:925 E:932 ||| VB
muscle  ||| S:932 E:939 ||| JJ
actin  ||| S:939 E:945 ||| JJ
immune  ||| S:945 E:952 ||| JJ
stain ||| S:952 E:957 ||| NN
.  ||| S:957 E:959 ||| .
The  ||| S:959 E:963 ||| DT
recurrence  ||| S:963 E:974 ||| JJ
rate  ||| S:974 E:979 ||| NN
after  ||| S:979 E:985 ||| IN
excision  ||| S:985 E:994 ||| NN
is  ||| S:994 E:997 ||| VBZ
low ||| S:997 E:1000 ||| JJ
.  ||| S:1000 E:1002 ||| .
